Yang Quanfu
a Department of Respiratory Medicine , The First Hospital of Tianshui , Tianshui , China.
Biosci Biotechnol Biochem. 2019 Feb;83(2):212-220. doi: 10.1080/09168451.2018.1540288. Epub 2018 Nov 2.
MiRNA-5195-3p (miR-5195-3p), a recently discovered and poorly studied miRNA, has been reported to suppress bladder cancer cell behavior. However, its regulatory role in non-small cell lung cancer (NSCLC) remains unclear. Here, the expression of miR-5195-3p was found to be reduced in NSCLC tissues and cells. The in vitro experiments showed that miR-5195-3p upregulation repressed cell proliferation, migration and invasion by CCK-8 and transwell assays. In addition, MYO6 was predicted and confirmed as a potential target of miR-5195-3p by Bioinformatics analysis, Luciferase reporter assay and western blot analysis. There was significantly negative correlation between miR-5195-3p and MYO6 in NSCLC tissues. Furthermore, MYO6 knockdown exhibited similar effects to those of miR-5195-3p overexpression in NSCLC cells, and restored MYO6 expression reversed the inhibitory effects of miR-5195-3p. Therefore, these results demonstrate that miR-5195-3p functions as a tumor suppressor by directly modulating MYO6 expression in NSCLC cells, and may be an innovative candidate target for NSCLC therapy.
微小RNA-5195-3p(miR-5195-3p)是一种最近发现但研究较少的微小RNA,据报道它可抑制膀胱癌细胞的行为。然而,其在非小细胞肺癌(NSCLC)中的调控作用仍不清楚。在此,研究发现miR-5195-3p在NSCLC组织和细胞中的表达降低。体外实验表明,通过CCK-8和Transwell实验,miR-5195-3p的上调可抑制细胞增殖、迁移和侵袭。此外,通过生物信息学分析、荧光素酶报告基因检测和蛋白质免疫印迹分析,预测并证实MYO6是miR-5195-3p的潜在靶标。在NSCLC组织中,miR-5195-3p与MYO6之间存在显著的负相关。此外,在NSCLC细胞中,敲低MYO6表现出与miR-5195-3p过表达类似的效果,而恢复MYO6表达则逆转了miR-5195-3p的抑制作用。因此,这些结果表明,miR-5195-3p通过直接调节NSCLC细胞中MYO6的表达发挥肿瘤抑制作用,可能是NSCLC治疗的一个创新候选靶点。